---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-016626"
form_type: "8-K"
ticker: "TLPH"
cik: "0001427925"
company_name: "TALPHERA, INC."
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T00:37:06.484774+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Talphera reports Q1 2024 net loss $4.0M; NEPHRO study enrollment delayed, guidance revised

## Summary
- Net loss from continuing ops $4.0M vs income $0.1M in Q1 2023; basic EPS -$0.16.
- Cash and investments $18.6M as of March 31, 2024.
- NEPHRO CRRT study enrollment delayed; top-line data guidance (by Sept 30) to be revised.
- Dr. Shakil Aslam appointed Chief Development Officer effective May 20, 2024.
- Combined R&D and SG&A expenses decreased to $4.2M from $5.3M year-over-year.

## SEC filing metadata
- accession: 0001437749-24-016626
- form_type: 8-K
- ticker: TLPH
- cik: 0001427925
- company_name: TALPHERA, INC.
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427925/000143774924016626/0001437749-24-016626-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427925/000143774924016626/acrx20240513_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-016626
- JSON: https://secwatch.observer/filing/0001437749-24-016626.json
- Plain text: https://secwatch.observer/filing/0001437749-24-016626.txt

## Key facts
- Earnings Releases
  TALPHERA, INC. reported the three months ended March 31, 2024 results: net income $4.0 million, EPS $0.16 per basic and diluted share.
  - Period: the three months ended March 31, 2024
  - Net income: $4.0 million
  - EPS: $0.16 per basic and diluted share
  - Result: reported results
  source text: Talphera, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1427925/000143774924016626/0001437749-24-016626-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.